EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Delirium Incidence and Predictors in SARS-CoV-2 Vaccinated Residents in Long-Term Care Facilities (LTCF): Insights from the GeroCovid Vax Study

Chukwuma Okoye, Maria Beatrice Zazzara, Chiara Ceolin, Giorgio Fedele, Annapina Palmieri, Angela Marie Abbatecola, Alba Malara, Caterina Trevisan, Suzanne Timmons, Rosa Prato, Francesca Fortunato, Susanna Del Signore und 5 weitere

Journal of the American Medical Directors Association · 2024

DOI: 10.1016/j.jamda.2024.105251 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Medical Directors Association, 2024. Verfasst von Chukwuma Okoye und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy; Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; Department o…. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Delirium, Long-Term Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Geriatric Medicine Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: SARS-CoV-2 vaccination can bring an important benefit for older people in terms of reduction of mortality and hospitalization; however, reports of rare adverse effects like altered consciousness and delirium among this demographic have raised concerns. This study aimed to assess delirium incidence post-SARS-CoV-2 vaccination and its predictors in older residents across 60 Italian long-term care facilities (LTCFs). DESIGN: This is a prospective cohort study considering data from GeroCovid Vax, a multicenter cohort study jointly performed by the Italian Society of Gerontology and Geriatrics (SIGG) (Florence, Italy) and the Italian National Institute of Health (Istituto Superiore di Sanità-ISS, Rome, Italy), and sponsored by the Italian Medicines Agency (Agenzia Italiana del Farmaco-AIFA). SETTING AND PARTICIPANTS: GeroCovid Vax enrolled LTCFs residents aged ≥60 who received at least 1 anti-SARS-CoV-2 vaccine dose. METHODS: Baseline data covered sociodemographic details, chronic diseases, medications, nutritional status, cognitive and functional assessments, mobility, and frailty. Delirium was assessed post-first, second, and booster vaccine doses using DSM-5 criteria. Data analysis involved descriptive statistics, multivariate logistic regression, and network analysis. RESULTS: A total of 2521 participants (mean age 83.10 ± 9.21 years, 70.7% female) were analyzed. Delirium incidence post-first, second, and booster doses was 3.5%, 1.6%, and 1.5%, respectively. Age, preexisting cognitive disorders, and frailty were significant predictors of delirium, with odds ratios (ORs) of 1.70 (95% CI, 1.08-2.77), 2.05 (95% CI, 1.40-2.97), and 1.77 (95% CI, 1.25-2.52), respectively. Prior use of antipsychotics (OR, 1.75; 95% CI, 1.22-2.51) and antidepressants (OR, 1.77; 95% CI, 1.25-2.52) correlated significantly with delirium. Network analysis indicated a strong association between anorexia and delirium. CONCLUSION AND IMPLICATIONS: Post-vaccination delirium is infrequent and decreases with subsequent doses. Timely assessments for frailty and cognitive impairment could aid in stratifying delirium risk among LTCF residents, facilitating enhanced prevention measures and close monitoring for delirium indicators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesDeliriumLong-Term CareAgedAged, 80 and overFemaleHumansMaleIncidenceItalyProspective StudiesSARS-CoV-2

Stichwörter der Autor:innen

COVID-19frailtylong-term facilitiesolder adultsvaccine

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy; Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; Department of Neurobiology, Care Sciences and Society, Aging Research Center, Karo…
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.
  • Department of Neurobiology, Care Sciences and Society, Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden; Department of Medicine (DIMED), Geriatrics Division, University of Padova,…
  • Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.
  • Alzheimer's Disease Day Clinic, Azienda Sanitaria Locale, Frosinone, Italy.

Förderung

  • European Geriatric Medicine Society

Zitieren

APA

Okoye, C., Zazzara, M. B., Ceolin, C., Fedele, G., Palmieri, A., Abbatecola, A. M., Malara, A., Trevisan, C., Timmons, S., Prato, R., Fortunato, F., Del Signore, S., Bellelli, G., Incalzi, R. A., Onder, G., Coin, A., & GeroCovid Vax Working Group (2024). Delirium Incidence and Predictors in SARS-CoV-2 Vaccinated Residents in Long-Term Care Facilities (LTCF): Insights from the GeroCovid Vax Study. Journal of the American Medical Directors Association. https://doi.org/10.1016/j.jamda.2024.105251

Vancouver

Okoye C, Zazzara MB, Ceolin C, Fedele G, Palmieri A, Abbatecola AM, et al. Delirium Incidence and Predictors in SARS-CoV-2 Vaccinated Residents in Long-Term Care Facilities (LTCF): Insights from the GeroCovid Vax Study. Journal of the American Medical Directors Association. 2024. doi:10.1016/j.jamda.2024.105251

BibTeX
@article{Okoye2024,
  author = {Okoye, Chukwuma and Zazzara, Maria Beatrice and Ceolin, Chiara and Fedele, Giorgio and Palmieri, Annapina and Abbatecola, Angela Marie and Malara, Alba and Trevisan, Caterina and Timmons, Suzanne and Prato, Rosa and Fortunato, Francesca and Del Signore, Susanna and Bellelli, Giuseppe and Incalzi, Raffaele Antonelli and Onder, Graziano and Coin, Alessandra and GeroCovid Vax Working Group, GeroCovid Vax Working Group},
  title = {Delirium Incidence and Predictors in SARS-CoV-2 Vaccinated Residents in Long-Term Care Facilities (LTCF): Insights from the GeroCovid Vax Study},
  journal = {Journal of the American Medical Directors Association},
  year = {2024},
  doi = {10.1016/j.jamda.2024.105251}
}
Kostenlos starten →